A detailed history of Summitry LLC transactions in Haleon PLC stock. As of the latest transaction made, Summitry LLC holds 33,992 shares of HLN stock, worth $329,722. This represents 0.02% of its overall portfolio holdings.

Number of Shares
33,992
Previous 32,463 4.71%
Holding current value
$329,722
Previous $268,000 33.96%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$8.32 - $10.7 $12,721 - $16,360
1,529 Added 4.71%
33,992 $359,000
Q2 2024

Aug 09, 2024

BUY
$8.01 - $8.64 $98,763 - $106,531
12,330 Added 61.24%
32,463 $268,000
Q1 2024

May 06, 2024

BUY
$8.02 - $8.67 $161,466 - $174,553
20,133 New
20,133 $170,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Summitry LLC Portfolio

Follow Summitry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summitry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summitry LLC with notifications on news.